Article Information
History
- October 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Angela Lovett1,
- Arlene C. Seña2,3,
- Andrew N. Macintyre4,
- Gregory D. Sempowski4,
- Joseph A. Duncan1,2,3,5,† and
- Andreea Waltmann3,†,*
- 1Department of Pharmacology, University of North Carolina, Chapel Hill, NC, United States
- 2Division of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, NC, United States
- 3Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- 4Department of Medicine and Duke Human Vaccine Institute, Duke University, Durham, NC, United States
- 5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- ↵* Corresponding author; email: waltmann{at}unc.edu
↵† These authors have contributed equally to this work and share senior authorship
Posted October 09, 2021.
